IGNITE Canada: Developing Pod System V15000 with Smart Screen Upgrade

Sep.20.2024

Canadian brand IGNITE drew attention at the Dortmund tobacco exhibition with its innovative products from September 19-21.

At the Dortmund Tobacco Expo from September 19 to 21, the Canadian brand IGNITE attracted a lot of attention with its innovative products. Lisa Kabatsky, Global Operations Manager of IGNITE International Brands, told 2Firsts that at this exhibition, IGNITE showcased two disposable products, v8000 and v15000. The v8000 was launched last year, while the v15000 was just released a few months ago and had not yet been introduced to the German market.

Lisa Kabatsky, Global Operations Manager of IGNITE International Brand, | Image source: 2Firsts

IGNITE has released disposable products v8000 and v15000. | Image source: 2Firsts.

IGNITEdisposable product v8000 | Image source: 2Firsts

Due to strict regulations in the local market, IGNITE is focusing on promoting low-nicotine products in the German market, while simultaneously developing switchable products that comply with regulations. Lisa Kabatsky stated that there is high demand for ice-flavored products in the German market, with no strong preference for other flavors and no noticeable trends.

IGNITE has expressed their views on the future trends of e-cigarettes to 2Firsts. Lisa Kabatsky believes that smart e-cigarettes are the way of the future, with the company upgrading their v15000 model and planning to equip it with a smart side screen to cater to the market's demand for smart products. Additionally, Lisa Kabatsky stated that IGNITE is also producing n-in-1 and 2+10 products, expected to be launched in the UK and EU regions, further expanding the company's market presence.

Lisa Kabatsky criticizes the regulatory policies issued by the United States FDA, stating that they have a negative impact on industry innovation and corporate development.

#Europe #Disposable e-cigarettes #Products #Germany

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

EU to Abstain from WHO Tobacco Treaty Vote Amid Deep Internal Split

The European Union will abstain from voting at the upcoming 11th session of the WHO Framework Convention on Tobacco Control (COP11) in Geneva, following months of internal disagreement over how to regulate tobacco and nicotine products. The decision marks a rare and public fracture in EU health policy, reportedly driven by the European Commission’s hardline anti-tobacco stance.

Nov.18 by 2FIRSTS.ai

Product | 2× “2+10” configuration, rated 36,000 puffs — VOZOL launches NEON PLUG MAX

VOZOL has listed a new product, NEON PLUG MAX, on its official website, featuring dual 2 ml prefilled pods and dual 10 ml refill bottles (24 ml total), a claimed maximum of 36,000 puffs, and two-flavour switching. The device was previously shown at InterTabac 2025 and was listed by the UK MHRA in March 2025; however, as of publication it was not yet available on overseas retail sites.

Oct.22 by 2FIRSTS.ai

Canadian Media Investigation: BAT’s Nicotine Pouch ZONNIC Sparks Ongoing Controversy as Regulatory Gaps in Canada Come Under Scrutiny

Canadian outlet Rebel News released a long-form video report examining Canada’s regulatory framework for nicotine pouches, market dynamics, and the approval process of ZONNIC, a product of BAT subsidiary Imperial Tobacco Canada. The report highlights issues involving youth access, regulatory gaps, black-market activity, retailer feedback, and company responses. This article summarizes key points based on the video.

Dec.02 by 2FIRSTS.ai

ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting

The U.S. FDA has scheduled a Tobacco Products Scientific Advisory Committee (TPSAC) meeting for January 22, 2026, to review Swedish Match USA’s Modified Risk Tobacco Product (MRTP) applications for 20 ZYN nicotine pouch products. Although the products gained PMTA authorization in early 2025, MRTP approval is required for marketing them with reduced-risk claims.